Navigation Links
Human Insulin Market Worth 39.13 Billion USD by 2020
Date:1/4/2016

PUNE, India, January 4, 2016 /PRNewswire/ --

According to a new market research report "Human Insulin Market - Drugs (Biologics, Biosimilars), Type (Short Acting, Long Acting, Premixed), Brands (Lantus, NovoRapid, Humalog), Delivery Devices (Pens, Pen Needles, Syringes), Applications (Type 1 Diabetes, Type 2 Diabetes) - Forecasts to 2020", published by MarketsandMarkets, The Global Human Insulin Market Is poised to reach ~USD 39.13 Billion by 2020, growing at a CAGR of 8.1% from 2015 to 2020 and studies the global market over the forecast period of 2015 to 2020.

Browse 75 market Tables and 53 Figures spread through 157 Pages and in-depth TOC on "Human Insulin Market"

http://www.marketsandmarkets.com/Market-Reports/human-insulin-market-229295783.html

Early buyers will receive 10% customization on this report. 

The market report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW)

On the basis of products, the global human insulin market is classified into two segments, namely, drugs and delivery devices. Human insulin drugs market has been further divided on the basis of drug type (rapid-acting, intermediate-acting, long-acting, short-acting, and premixed) and drug brands (Lantus, NovoRapid/Novolog, Humalog, Humulin, Insuman, Actrapid, Insulatard, Mixtard, and Other Biosimilar Brands). Furthermore, human insulin delivery devices market is segmented into insulin pens (reusable & disposable), pen needles (standard & safety), and conventional syringes. Additionally, global human insulin market is classified on the basis of applications into type I diabetes applications and type II diabetes applications.

Factors such as growing diabetes patient population, increasing population exposure to key risk factors leading to diabetes, rising market demand for human insulin analogs, technological advancements in the field of human insulin delivery devices, and favorable medical reimbursements are driving the growth of human insulin market during the forecast period. However, stringent regulatory requirements for product approval are restraining the growth of this market.

In 2015, North America is expected to hold the largest share of the human insulin market, followed by Europe. Additionally, Asia-Pacific is expected to grow at the highest CAGR during the forecast period (2015 to 2020). Strong market growth witnessed in the North American human insulin market can be attributed to factors such as significant patent protection for several human insulin biosimilar brands in the U.S., continuous updation of medical reimbursement guidelines in the U.S. for diabetes treatment, and extensive & well-established distribution network of market players for human insulin products.

Ask for PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=229295783

Sanofi (France), Novo Nordisk A/S (Denmark), Eli Lilly and Company (U.S.), Biocon Ltd. (India), Julphar (U.A.E.), Ypsomed AG (Switzerland), Becton, Dickinson and Company (U.S.), Wockhardt Ltd. (India), B. Braun Meselgen AG (Switzerland), and Biodel Inc. (U.S.) are some of the key players operating in the Global Human Insulin Market.

Browse Related Reports: 

Protein Engineering Market by Technology (Rational Protein Design, Irrational Protein Design), Product (Instrument, Services), Protein Type (Monoclonal Antibodies, Interferon, Growth Hormone), End User (Academics Institutes, CROs) - Global Forecast to 2020

http://www.marketsandmarkets.com/Market-Reports/protein-antibody-engineering-market-898.html

Biosimilars Market by Product (Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Interferons, rHGH), Glycosylated (Monoclonal Antibodies, EPO), Peptides (Glucagon, Calcitonin)) & Application (Oncology, Blood Disorders) - Global Forecast to 2020

http://www.marketsandmarkets.com/Market-Reports/biosimilars-40.html

About MarketsandMarkets  

MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets



'/>"/>
SOURCE MarketsandMarkets
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Janssen Announces Collaboration with Bavarian Nordic to Develop Vaccine for Chronic Human Papillomavirus (HPV) Infections
2. A Product and Pipeline Analysis of the Human Plasma-derived Therapeutics Market
3. Global Human Insulin Market Expected to Reach $48,488 Million Value By 2020 by P&S Market Research
4. Students Present Novel Scientific Ideas Through Low-Cost Infant Respiratory Device and 3D Printed Human Tissue
5. Boehringer Ingelheim Awarded Perfect Score on Human Rights Campaign Foundations Corporate Equality Index
6. Boston Scientific Scores Perfect 100 on Human Rights Campaigns 2016 Corporate Equality Index
7. Johnson & Johnson Announces $1.75 Million Donation to Save the Children to Support Syrian Humanitarian Refugee Crisis
8. Humanwell PuraCap Pharmaceutical LLC Announces Successful FDA Inspection
9. Weltweit erste Humanimplantation des endovaskulären Neuromodulationsimplantats zur Behandlung von Herzinsuffizienz
10. The International Papillomavirus Society Endorses Human Papillomavirus Vaccines
11. Lungpacer Medical, Inc. Announces Start of First-in-Human Early Feasibility Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2020)... ... January 23, 2020 , ... FiteBac® Cavity ... exposed dentin tubules allowing restorative adhesives to tightly bind to the prepared dentin ... FiteBac® Cavity Cleanser with 2% K21. Cavity cleansers are intended for cleansing ...
(Date:1/23/2020)... (PRWEB) , ... January 23, 2020 , ... Please join ... she begins her term as the Society’s president for 2020. Dr. Dorbala is the ... and is an associate professor of radiology at Harvard. Over more than 20 years ...
(Date:1/23/2020)... ... , ... “It’s complicated.” The phrase may apply to some ... a person’s hand, wrist, arm and shoulder. “Which is why patients should contact ... goes wrong up or down this superhighway of interconnected bones, joints, tendons, ligaments, ...
Breaking Medicine Technology:
(Date:1/24/2020)... ... January 24, 2020 , ... SweetLeaf Stevia ... expert and best-selling nutrition author Jorge Cruise to educate consumers on losing weight ... an enthusiastic advocate of intermittent fasting, that is fat burning and boosting your ...
(Date:1/23/2020)... ... ... SignatureCare Emergency Center is set to expand to North Dallas with the opening of ... of Lewisville, on 1596 W. Main St., Lewisville, TX 75067, the new location will ... It will serve residents and businesses around Lewisville, TX, including Double Oak, Copper Canyon, ...
(Date:1/23/2020)... ... January 23, 2020 , ... ... impairment, has announced the Best Memory Care Facilities in Santa Rosa, California. The ... features and amenities. , According to the Alzheimer’s Association , 5.6 ...
(Date:1/23/2020)... ... January 23, 2020 , ... ... and services that improve workforce resilience, is presenting at the NATSAP 2020 Conference. ... advocate and resource for organizations that devote themselves to society’s need for the ...
(Date:1/23/2020)... ... January 23, 2020 , ... This week, SocialClimb ... to power the Arrowlytics platform and deliver its key performance indicators (KPIs) to ... with practice management systems to extract the data necessary to enable Arrowlytics. , ...
Breaking Medicine News(10 mins):